Are There Differences Between the Available Treatments for Emphysema Associated with Alpha-1 Antitrypsin Deficiency?

Arch Bronconeumol (Engl Ed). 2018 Sep;54(9):451-452. doi: 10.1016/j.arbres.2018.01.006. Epub 2018 Apr 4.

[Article in English, Spanish]

Authors

Cristina Esquinas¹, Marc Miravitlles²

Affiliations

¹ Servicio de Neumología, Hospital Universitari Vall d'Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, España.
² Servicio de Neumología, Hospital Universitari Vall d'Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, España. Electronic address: mmiravitlles@vhebron.net.

PMID: 29625713
DOI: 10.1016/j.arbres.2018.01.006

No abstract available

Publication types

Comparative Study
Editorial

MeSH terms

Humans
Pulmonary Emphysema / drug therapy*
Pulmonary Emphysema / etiology
Spain
alpha 1-Antitrypsin / therapeutic use*
alpha 1-Antitrypsin Deficiency / complications

Substances

Respreeza
alpha 1-Antitrypsin